Notably, tumor-derived exosomes express PD-L1 on their surface, which suppresses CD8 T cell function, thereby promoting tumor growth and influencing the outcome of anti-PD-1 therapy (Chatterjee et al., 2021). Here, CD8A is linked to neoplasm.